Suven Life Sciences Limited (SUVEN) — Corporate Action | 22 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Suven Life Sciences approved the allotment of 271,970 equity shares at Rs 55 per share upon exercise of vested options under its 2020 ESOP, increasing paid-up capital to Rs 26,39,92,553. The transaction generated Rs 1.5 crore in proceeds and maintains pari-passu rights with existing shares.

📄 View Original Announcement (PDF)

About Suven Life Sciences Limited (SUVEN)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹11,087.76 Cr ROE: -80.9% ROCE: -80.7%

View full SUVEN stock details →

📡 Get AI alerts when SUVEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUVEN — Free

📊 More SUVEN filings

See all SUVEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUVEN files new disclosures

Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUVEN — Free

Free account · 2 AI queries/day